Is Basilea Pharmaceutica AG stock a buy?

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Basilea Pharmaceutica AG 10 years ago, but if you had invested on Friday 6th of August 2021 when the price was CHF43.70, you would have made a loss of CHF-3.19 per share or -7.30%

No, the average daily trading liquidity for Basilea Pharmaceutica AG is CHF4 885 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Basilea Pharmaceutica AG has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.10, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Basilea Pharmaceutica AG to be high [0.75 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.